Diagnostic Utility of a Custom 34-Gene Anchored Multiplex PCR-Based Next-Generation Sequencing Fusion Panel for the Diagnosis of Bone and Soft Tissue Neoplasms With Identification of Novel USP6 Fusion Partners in Aneurysmal Bone Cysts.

* Context.--Bone and soft tissue tumors are heterogeneous, diagnostically challenging, and often defined by gene fusions. Objective.--To present our experience using a custom 34-gene targeted sequencing fusion panel. Design.--Total nucleic acid extracted from formalin-fixed, paraffin-embedded (FFPE)...

Descripción completa

Detalles Bibliográficos
Publicado en:Archives of Pathology & Laboratory Medicine Vol. 145; no. 7; pp. 851 - 864
Autores principales: Dermawan, Josephine K., Yu Wei Cheng, Zheng Jin Tu, Meyer, Anders, Habeeb, Omar, Youran Zou, Goldblum, John R., Billings, Steven D., Kilpatrick, Scott E., Reith, John D., Shurtleff, Sheila A., Farkas, Daniel H., Rubin, Brian P., Azzato, Elizabeth M.
Formato: pictorial research tables/charts Journal Article
Publicado: College of American Pathologists Jul2021
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=151030729&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 151030729
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00039985
        1FS
      jtl: Archives of Pathology & Laboratory Medicine
      issn: 00039985
      maglogo: N
    pubinfo:
      dt: Jul2021
      vid: 145
      iid: 7
      pid: 2550
      pub: College of American Pathologists
      place: Northfield, Illinois
    artinfo:
      ui:
        151030729
        151030729
        151030729
        10.5858/arpa.2020-0336-OA
        151030729
      ppf: 851
      ppct: 13
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Diagnostic Utility of a Custom 34-Gene Anchored Multiplex PCR-Based Next-Generation Sequencing Fusion Panel for the Diagnosis of Bone and Soft Tissue Neoplasms With Identification of Novel USP6 Fusion Partners in Aneurysmal Bone Cysts.
      aug:
        au:
          Dermawan, Josephine K.
          Yu Wei Cheng
          Zheng Jin Tu
          Meyer, Anders
          Habeeb, Omar
          Youran Zou
          Goldblum, John R.
          Billings, Steven D.
          Kilpatrick, Scott E.
          Reith, John D.
          Shurtleff, Sheila A.
          Farkas, Daniel H.
          Rubin, Brian P.
          Azzato, Elizabeth M.
        affil: Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio
      sug:
        subj:
          Bone Neoplasms Diagnosis
          Soft Tissue Neoplasms Diagnosis
          Polymerase Chain Reaction Methods
          Bone Cysts, Aneurysmal
          Human
          Descriptive Statistics
          Sequence Analysis
      ab: * Context.--Bone and soft tissue tumors are heterogeneous, diagnostically challenging, and often defined by gene fusions. Objective.--To present our experience using a custom 34-gene targeted sequencing fusion panel. Design.--Total nucleic acid extracted from formalin-fixed, paraffin-embedded (FFPE) tumor specimens was subjected to open-ended, nested anchored multiplex polymerase chain reaction and enrichment of 34 gene targets, thus enabling detection of known and novel fusion partners. Results.--During a 12-month period, 147 patients were tested as part of routine clinical care. Tumor percentage ranged from 10% to 100% and turnaround time ranged from 3 to 15 (median, 7.9) days. The most common diagnostic groups were small round blue cell tumors, tumors of uncertain differentiation, fibroblastic/myofibroblastic tumors, and adipocytic tumors. In-frame fusion transcripts were identified in 64 of 142 cases sequenced (45%): in 62 cases, the detection of a disease-defining fusion confirmed the morphologic impression; in 2 cases, a germline TFG-GPR128 polymorphic fusion variant was detected. Several genes in the panel partnered with multiple fusion partners specific for different diagnoses, for example, EWSR1, NR4A3, FUS, NCOA2, and TFE3. Interesting examples are presented to highlight how fusion detection or lack thereof was instrumental in establishing accurate diagnoses. Novel fusion partners were detected for 2 cases of solid aneurysmal bone cysts (PTBP1-USP6, SLC38A2-USP6). Conclusions.--Multiplex detection of fusions in total nucleic acid purified from FFPE specimens facilitates diagnosis of bone and soft tissue tumors. This technology is particularly useful for morphologically challenging entities and in the absence of prior knowledge of fusion partners, and has the potential to discover novel fusion partners.
      pubtype: Academic Journal
      doctype:
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N